Literature DB >> 19324057

Existence of a noncanonical state of iron-bound transferrin at endosomal pH revealed by hydrogen exchange and mass spectrometry.

Cedric E Bobst1, Mingxuan Zhang, Igor A Kaltashov.   

Abstract

Transferrin (Tf) is an enigmatic metalloprotein that exhibits a profound conformational change upon binding of ferric ion and a synergistic anion (oxalate or carbonate). While the apo and holo forms of the protein have well-defined and stable conformations termed "open" and "closed," certain aspects of Tf behavior imply the existence of alternative protein states. In this work, hydrogen/deuterium exchange was used in combination with mass spectrometry to map solvent-accessible surfaces of the iron-bound and iron-free forms of the N-terminal lobe of human serum Tf at both neutral and endosomal pH levels. While the deuterium uptake is significantly decelerated in the iron-bound state of the protein (compared with the apo form) at neutral pH, the changes are distributed very unevenly across the protein sequence. Protein segments exhibiting most noticeable gain in protection map onto the interdomain cleft region housing the iron-binding site. At the same time, protection levels of segments located in the bulk of the protein are largely unaffected by the presence of the metal. These observations are fully consistent with the notion of a metal-induced switch from the open to the closed conformation with solvent-inaccessible interdomain cleft. However, differences in the exchange behavior between the apo and holo forms of Tf become much less noticeable at endosomal pH, including the segments located in the interdomain cleft region. Intriguingly, a significant patch in the cleft region becomes slightly less protected in the presence of the metal, suggesting that the holoprotein exists in the open conformation under these slightly acidic conditions. The existence of a noncanonical state of holoTf was postulated several years ago; however, this work provides, for the first time, conclusive evidence that such alternative states are indeed populated in solution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19324057      PMCID: PMC2933096          DOI: 10.1016/j.jmb.2009.03.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  37 in total

1.  Transferrin as a metal ion mediator.

Authors:  H Sun; H Li; P J Sadler
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Use of different proteases working in acidic conditions to improve sequence coverage and resolution in hydrogen/deuterium exchange of large proteins.

Authors:  Laetitia Cravello; David Lascoux; Eric Forest
Journal:  Rapid Commun Mass Spectrom       Date:  2003       Impact factor: 2.419

3.  Molecular evolution of affinity and flexibility in the immune system.

Authors:  Ian F Thorpe; Charles L Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-08       Impact factor: 11.205

4.  (Thermo)dynamic role of receptor flexibility, entropy, and motional correlation in protein-ligand binding.

Authors:  Riccardo Baron; J Andrew McCammon
Journal:  Chemphyschem       Date:  2008-05-16       Impact factor: 3.102

5.  The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.

Authors:  Anthony M Giannetti; Peter J Halbrooks; Anne B Mason; Todd M Vogt; Caroline A Enns; Pamela J Björkman
Journal:  Structure       Date:  2005-11       Impact factor: 5.006

Review 6.  Transferrin, the transferrin receptor, and the uptake of iron by cells.

Authors:  P Aisen
Journal:  Met Ions Biol Syst       Date:  1998

7.  Intrinsic fluorescence reports a global conformational change in the N-lobe of human serum transferrin following iron release.

Authors:  Nicholas G James; Christopher L Berger; Shaina L Byrne; Valerie C Smith; Ross T A MacGillivray; Anne B Mason
Journal:  Biochemistry       Date:  2007-08-21       Impact factor: 3.162

Review 8.  Hydrogen exchange methods to study protein folding.

Authors:  Mallela M G Krishna; Linh Hoang; Yan Lin; S Walter Englander
Journal:  Methods       Date:  2004-09       Impact factor: 3.608

9.  Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferrin.

Authors:  P D Jeffrey; M C Bewley; R T MacGillivray; A B Mason; R C Woodworth; E N Baker
Journal:  Biochemistry       Date:  1998-10-06       Impact factor: 3.162

10.  Entropic contributions and the influence of the hydrophobic environment in promiscuous protein-protein association.

Authors:  Chia-En A Chang; William A McLaughlin; Riccardo Baron; Wei Wang; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-21       Impact factor: 11.205

View more
  13 in total

1.  Impact of oxidation on protein therapeutics: conformational dynamics of intact and oxidized acid-β-glucocerebrosidase at near-physiological pH.

Authors:  Cedric E Bobst; John J Thomas; Paul A Salinas; Philip Savickas; Igor A Kaltashov
Journal:  Protein Sci       Date:  2010-12       Impact factor: 6.725

2.  Electrostatic effects control the stability and iron release kinetics of ovotransferrin.

Authors:  Sandeep Kumar; Deepak Sharma; Rajesh Kumar; Rajesh Kumar
Journal:  J Biol Inorg Chem       Date:  2014-05-22       Impact factor: 3.358

Review 3.  Transferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Mingxuan Zhang; Rachael Leverence; Dmitry R Gumerov
Journal:  Biochim Biophys Acta       Date:  2011-06-25

Review 4.  Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Guanbo Wang; Burcu Baykal; Shunhai Wang
Journal:  Biotechnol Adv       Date:  2011-05-17       Impact factor: 14.227

5.  Conserved interaction between transferrin and transferrin-binding proteins from porcine pathogens.

Authors:  Leslie P Silva; Ronghua Yu; Charles Calmettes; Xue Yang; Trevor F Moraes; Anthony B Schryvers; David C Schriemer
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

6.  Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.

Authors:  Hanwei Zhao; Shunhai Wang; Son N Nguyen; S Gokhan Elci; Igor A Kaltashov
Journal:  J Am Soc Mass Spectrom       Date:  2015-09-21       Impact factor: 3.109

7.  Detailed molecular dynamics simulations of human transferrin provide insights into iron release dynamics at serum and endosomal pH.

Authors:  Haleh Abdizadeh; Ali Rana Atilgan; Canan Atilgan
Journal:  J Biol Inorg Chem       Date:  2015-03-20       Impact factor: 3.358

8.  Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Rinat R Abzalimov; Steven A Berkowitz; Damian Houde
Journal:  J Am Soc Mass Spectrom       Date:  2009-10-29       Impact factor: 3.109

Review 9.  Mass spectrometry-based methods in characterization of the higher order structure of protein therapeutics.

Authors:  Igor A Kaltashov; Cedric E Bobst; Jake Pawlowski; Guanbo Wang
Journal:  J Pharm Biomed Anal       Date:  2020-02-12       Impact factor: 3.935

10.  Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery.

Authors:  Cedric E Bobst; Shunhai Wang; Wei-Chiang Shen; Igor A Kaltashov
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.